Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.07 Billion CNY | 18.62% |
| 2022 | 1.63 Billion CNY | 34.0% |
| 2021 | 1.24 Billion CNY | 3.89% |
| 2020 | 1.18 Billion CNY | 23.89% |
| 2019 | 958.1 Million CNY | 8.64% |
| 2018 | 847.92 Million CNY | 28.02% |
| 2017 | 665.82 Million CNY | 35.08% |
| 2016 | 499.41 Million CNY | 65.02% |
| 2015 | 303.26 Million CNY | -0.11% |
| 2014 | 302.65 Million CNY | 79.38% |
| 2013 | 170.55 Million CNY | 83.57% |
| 2012 | 90.72 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 543.79 Million CNY | -10.37% |
| 2024 Q1 | 487.55 Million CNY | -6.56% |
| 2024 Q2 | 586.9 Million CNY | 12.49% |
| 2023 Q1 | 398.04 Million CNY | -6.17% |
| 2023 FY | - CNY | 18.62% |
| 2023 Q4 | 547.56 Million CNY | 13.54% |
| 2023 Q3 | 482.26 Million CNY | 3.97% |
| 2023 Q2 | 463.83 Million CNY | 16.53% |
| 2022 FY | - CNY | 34.0% |
| 2022 Q1 | 366.61 Million CNY | 1.97% |
| 2022 Q4 | 424.2 Million CNY | 2.67% |
| 2022 Q3 | 413.17 Million CNY | 39.63% |
| 2022 Q2 | 295.9 Million CNY | -19.29% |
| 2021 FY | - CNY | 3.89% |
| 2021 Q4 | 359.52 Million CNY | 32.1% |
| 2021 Q3 | 272.15 Million CNY | -12.59% |
| 2021 Q1 | 166.19 Million CNY | -42.61% |
| 2021 Q2 | 311.36 Million CNY | 87.35% |
| 2020 Q1 | 110.11 Million CNY | -55.92% |
| 2020 Q4 | 289.59 Million CNY | 10.21% |
| 2020 FY | - CNY | 23.89% |
| 2020 Q2 | 419.5 Million CNY | 280.96% |
| 2020 Q3 | 262.76 Million CNY | -37.36% |
| 2019 Q3 | 242.3 Million CNY | 6.53% |
| 2019 Q2 | 227.45 Million CNY | 38.13% |
| 2019 Q1 | 164.67 Million CNY | 0.0% |
| 2019 Q4 | 249.82 Million CNY | 3.1% |
| 2019 FY | - CNY | 8.64% |
| 2018 FY | - CNY | 28.02% |
| 2017 FY | - CNY | 35.08% |
| 2016 Q1 | 111.18 Million CNY | 84.73% |
| 2016 FY | - CNY | 65.02% |
| 2016 Q4 | 142.15 Million CNY | 0.0% |
| 2016 Q3 | 142.15 Million CNY | 27.85% |
| 2016 Q2 | 111.18 Million CNY | 0.0% |
| 2015 Q3 | 60.18 Million CNY | -24.21% |
| 2015 Q2 | 79.41 Million CNY | -0.0% |
| 2015 Q1 | 79.41 Million CNY | -1.16% |
| 2015 Q4 | 60.18 Million CNY | 0.0% |
| 2015 FY | - CNY | -0.11% |
| 2014 FY | - CNY | 79.38% |
| 2014 Q2 | 59.04 Million CNY | -0.0% |
| 2014 Q1 | 59.04 Million CNY | 17.0% |
| 2014 Q4 | 80.35 Million CNY | 0.0% |
| 2014 Q3 | 80.35 Million CNY | 36.09% |
| 2013 Q2 | 31.82 Million CNY | -0.0% |
| 2013 Q4 | 50.46 Million CNY | 0.0% |
| 2013 FY | - CNY | 83.57% |
| 2013 Q3 | 50.46 Million CNY | 58.57% |
| 2013 Q1 | 31.82 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |